Waltham, MA
Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.
jadebiosciences.comThese are collections Jade Biosciences is a part of. Click on the collection name to view similar companies.
Post Ipo Equity
$135,000,000
Post Ipo Equity
$300,000,000
Series A
$95,000,000
IPO
Unknown
Series A
$72,600,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Jade Biosciences.